NASDAQ Companies

Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, […]

LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]

CULVER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global […]

MOLINE, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) announced today that its fourth quarter and fiscal […]

FORT LAUDERDALE, Fla., Jan. 03, 2024 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi” or the “Company”), owner […]

SOUTH JORDAN, Utah, Jan. 03, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and […]

CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new […]

11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time LOS ANGELES, CA, Jan. 03, 2024 (GLOBE NEWSWIRE) — Oaktree Specialty […]

ENGLEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) is pleased to announce that Katie Ellet has […]

-Dr. Praveen Tipirneni, returns in full capacity as Chief Executive Officer from medical leave- WALTHAM, Mass., Jan. 03, 2024 (GLOBE […]